Your browser doesn't support javascript.
loading
Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design.
Berge, Trygve; Vigen, Thea; Pervez, Mohammad Osman; Ihle-Hansen, Haakon; Lyngbakken, Magnus Nakrem; Omland, Torbjørn; Smith, Pål; Steine, Kjetil; Røsjø, Helge; Tveit, Arnljot.
Afiliação
  • Berge T; a Department of Medical Research , Baerum Hospital, Vestre Viken Hospital Trust , Norway.
  • Vigen T; c Institute of Clinical Medicine, University of Oslo , Oslo , Norway.
  • Pervez MO; b Division of Medicine, Akershus University Hospital , Lørenskog , Norway.
  • Ihle-Hansen H; c Institute of Clinical Medicine, University of Oslo , Oslo , Norway.
  • Lyngbakken MN; b Division of Medicine, Akershus University Hospital , Lørenskog , Norway.
  • Omland T; c Institute of Clinical Medicine, University of Oslo , Oslo , Norway.
  • Smith P; a Department of Medical Research , Baerum Hospital, Vestre Viken Hospital Trust , Norway.
  • Steine K; c Institute of Clinical Medicine, University of Oslo , Oslo , Norway.
  • Røsjø H; b Division of Medicine, Akershus University Hospital , Lørenskog , Norway.
  • Tveit A; c Institute of Clinical Medicine, University of Oslo , Oslo , Norway.
Scand Cardiovasc J ; 49(6): 308-15, 2015.
Article em En | MEDLINE | ID: mdl-26364744
ABSTRACT

OBJECTIVES:

The aim of the Akershus Cardiac Examination (ACE) 1950 Study is to investigate the development and progression of cardiovascular and cerebrovascular disease (CVD/CeVD) in an extensively characterized age cohort of middle-aged subjects with longitudinal long-term follow-up.

DESIGN:

The ACE 1950 Study is a prospective, population-based, age-cohort study of all men and women born in 1950 in Akershus County, Norway. The study involves a comprehensive baseline examination, especially for CVD/CeVD, including advanced ultrasound imaging and biobanking ("deep phenotyping"). We expect to obtain an inclusion rate of > 60% from the total study population of 5,827 eligible subjects. Enrollment will be completed during 2015.

CONCLUSIONS:

The ACE 1950 Study will have potential to generate new and relevant insight into identification of subclinical disease progression. Extensive phenotyping will enable identification of novel disease markers and mechanisms for subclinical disease, which can prove important for future disease prevention.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Transtornos Cerebrovasculares / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Scand Cardiovasc J Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Transtornos Cerebrovasculares / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Scand Cardiovasc J Ano de publicação: 2015 Tipo de documento: Article